Ruth Plummer is Professor of Experimental Cancer Medicine at the Newcastle University and Director of the Sir Bobby Robson Cancer Trials Research Centre. She leads the Newcastle Experimental Cancer Medicine Centre and also the CRUK Newcastle Cancer Centre. Her research interests are in the field of DNA repair and early phase clinical trials of novel agents, taking the first in class PARP, ATR and MCT1 inhibitors into the clinic.

Nationally she chairs the CRUK New Agents Committee, and sits as a member of CRUK Clinical Research Committee.